Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models

The accumulation of iron may contribute to Alzheimer’s disease (AD) and other tauopathies. The iron chelator desferrioxamine slows disease progression in AD patients. However, desferrioxamine requires injection, which is inconvenient and may hinder compliance. We therefore tested an oral iron chelat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Ping, Ho, Amy, Baum, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945800/
https://www.ncbi.nlm.nih.gov/pubmed/35327557
http://dx.doi.org/10.3390/biom12030365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945800/
https://www.ncbi.nlm.nih.gov/pubmed/35327557
http://dx.doi.org/10.3390/biom12030365

Ejemplares similares